Conspectus
The discovery of previously
unknown functional roles of RNA in
biological systems has led to increased interest in revealing novel
RNA molecules as therapeutic targets and the development of tools
to better understand the role of RNA in cells. RNA metabolic labeling
broadens the scope of studying RNA by incorporating of unnatural nucleobases
and nucleosides with bioorthogonal handles that can be utilized for
chemical modification of newly synthesized cellular RNA. Such labeling
of RNA provides access to applications including measurement of the
rates of synthesis and decay of RNA, cellular imaging for RNA localization,
and selective enrichment of nascent RNA from the total RNA pool. Several
unnatural nucleosides and nucleobases have been shown to be incorporated
into RNA by endogenous RNA synthesis machinery of the cells. RNA metabolic
labeling can also be performed in a cell-specific manner, where only
cells expressing an essential enzyme incorporate the unnatural nucleobase
into their RNA. Although several discoveries have been enabled by
the current RNA metabolic labeling methods, some key challenges still
exist: (i) toxicity of unnatural analogues, (ii) lack of RNA-compatible
conjugation chemistries, and (iii) background incorporation of modified
analogues in cell-specific RNA metabolic labeling. In this Account,
we showcase work done in our laboratory to overcome these challenges
faced by RNA metabolic labeling.
To begin, we discuss the cellular
pathways that have been utilized
to perform RNA metabolic labeling and study the interaction between
nucleosides and nucleoside kinases. Then we discuss the use of vinyl
nucleosides for metabolic labeling and demonstrate the low toxicity
of 5-vinyluridine (5-VUrd) compared to other widely used nucleosides.
Next, we discuss cell-specific RNA metabolic labeling with unnatural
nucleobases, which requires the expression of a specific phosphoribosyl
transferase (PRT) enzyme for incorporation of the nucleobase into
RNA. In the course of this work, we discovered the enzyme uridine
monophosphate synthase (UMPS), which is responsible for nonspecific
labeling with modified uracil nucleobases. We were able to overcome
this background labeling by discovering a mutant uracil PRT (UPRT)
that demonstrates highly specific RNA metabolic labeling with 5-vinyluracil
(5-VU). Furthermore, we discuss the optimization of inverse-electron-demand
Diels–Alder (IEDDA) reactions for performing chemical modification
of vinyl nucleosides to achieve covalent conjugation of RNA without
transcript degradation. Finally, we highlight our latest endeavor:
the development of mutually orthogonal chemical reactions for selective
labeling of 5-VUrd and 2-vinyladenosine (2-VAdo), which allows for
potential use of multiple vinyl nucleosides for simultaneous investigation
of multiple cellular processes involving RNA. We hope that our methods
and discoveries encourage scientists studying biological systems to
include RNA metabolic labeling in their toolkit for studying RNA and
its role in biological...